Lung Function, Coronary Artery Disease, and Mortality in HIV
Divay Chandra1, Aman Gupta1, Meghan Fitzpatrick1
11 Department of Medicine.
Insights
Reduced lung diffusing capacity (DlCO) is linked to coronary artery disease (CAD) and increased mortality in people with HIV. This association highlights the importance of lung health in cardiovascular outcomes for this population.
Area of Science:
- Cardiology
- Pulmonology
- Infectious Diseases
Background:
- Impaired lung function predicts coronary artery disease (CAD) in the general population.
- The link between lung function and CAD in individuals with human immunodeficiency virus (HIV) is not well-defined.
- Understanding this relationship is crucial for managing cardiovascular risk in HIV-infected individuals.
Purpose of the Study:
- To investigate the association between lung function, CAD, and mortality in HIV-infected individuals.
- To identify circulating biomarkers related to lung function and CAD in HIV.
- To validate findings in independent cohorts.
Main Methods:
- Cohort study including HIV-infected and uninfected participants.
- Assessment of spirometry, diffusing capacity of the lung for carbon monoxide (DlCO), emphysema, and coronary artery calcium (CAC).
- Analysis of mortality data and circulating biomarkers (e.g., Endothelin-1, intercellular adhesion molecule 1); validation in the Multicenter AIDS Cohort Study (MACS).
Main Results:
- Lower DlCO, but not other lung function measures, was independently associated with greater CAC in HIV-infected individuals.
- HIV-infected individuals with both reduced DlCO and CAC had significantly higher mortality.
- Endothelin-1 was associated with both lower DlCO and greater CAC in the HIV cohort.
Conclusions:
- Impaired DlCO is associated with CAD and increased mortality in individuals with HIV.
- The combination of reduced DlCO and CAD confers the highest mortality risk.
- Lung function assessment may aid in cardiovascular risk stratification for people with HIV.
Abstract:
Rationale: Impaired lung function is a potent independent predictor of coronary artery disease (CAD) in individuals without human immunodeficiency virus (HIV) infection; however, the relationship between lung function and CAD in HIV remains undefined. Objectives: To examine the relationship between lung function, CAD, mortality, and circulating biomarkers in HIV. Methods: Spirometry, diffusing capacity of the lung for carbon monoxide (DlCO), emphysema, coronary artery calcium, mortality, cause of death, and biomarkers were examined in HIV-infected and uninfected individuals enrolled in a cohort study at the University of Pittsburgh. Results were then validated in the Multicenter AIDS Cohort Study (MACS) cohort. Results: We examined data on 234 participants in the Pittsburgh cohort. The mean ± standard deviation age was 49.5 ± 10.2 years old, 82.1% were male, and 67.5% were ever smokers. Among the 177 of 234 individuals with HIV infection, lower DlCO (not forced expiratory volume in 1 second or emphysema) was independently associated with greater coronary artery calcium (odds ratio, 1.43 per 10% lower DlCO; 95% confidence interval, 1.14-1.81). HIV-infected individuals with both reduced DlCO and coronary artery calcium had a much higher mortality than those with either low DlCO or coronary calcium alone or with neither condition. Endothelin-1, a circulating biomarker of endothelial dysfunction, was associated with both lower DlCO and greater coronary artery calcium in those with HIV infection. Results were reproducible in 144 individuals enrolled in the MACS cohort; intercellular adhesion molecule 1 was the biomarker of endothelial dysfunction assessed in the MACS cohort. Conclusions: Impaired DlCO and CAD were associated with each other and with higher mortality in individuals with HIV infection.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
05:56Author Spotlight: Enhancing Diagnostic Strategies and Biomarker Development for Comprehensive Lung Function Analysis
Published on: August 9, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease I: Introduction
